Abbott says MitraClip system safer than surgery in study

05/26/2010 | Bloomberg Businessweek

Abbott Laboratories said an analysis of study data showed that its MitraClip system, a heart valve clip designed to reduce mitral regurgitation, had lower rates of major adverse events than surgery. A spokesman for Abbott said the device will be reviewed by an FDA panel later this year, and the company expects to get approval next year.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT